Sen. Kyrsten Sinema (D-AZ) this past quarter raised $1.1 million -- and 90 percent of it came from out-of-state donors, including a who's who of pharmaceutical company executives.
Politico reports that Sinema "received $27,800 from PACs of pharmaceutical companies from July through September" and also received several individual donations from pharma execs, including $5,000 from Gilead CEO, Daniel O'Day, $2,900 from Eli Lilly CEO David Ricks, and $2,900 from Kenneth C. Frazier, the chairman of the board at Merck.
News of the donations comes as Sinema has been threatening to block Democrats from allowing Medicare to negotiate drug prices with major pharmaceutical firms.
In addition to raking in cash from Big Pharma, Sinema also posted a substantial haul from the financial services industry, Politico reports.
"PACs for the financial services industry — another sector facing potential new regulation in Congress — gave more than $50,000," reports Politico. "Goldman Sachs president John Waldron made a maximum donation of $5,800. Two senior managing directors at Blackstone — Giovani Cutaia and Eli Nagler — collectively gave $5,700, and a managing director of government relations there, Alex Katz, donated $1,000."